Difference between revisions of "Part:BBa K1329005"

 
Line 4: Line 4:
 
<html><h2>Idea</h2></html>
 
<html><h2>Idea</h2></html>
  
Our approach was to make it possible to combine the advantages of the nonribosomal peptide  
+
Our approach was to realization the advantages of the nonribosomal peptide  
synthesis with the ribosomal pathway, i.e. the enormous repertoire of amino acids  
+
synthesis (NRPS) with the ribosomal pathway, i.e. the enormous repertoire of amino acids  
 
combined with the ability of the ribosome to synthesize huge proteins. To reach that aim,  
 
combined with the ability of the ribosome to synthesize huge proteins. To reach that aim,  
we planed to create a phusion protein that has the capability to activate amino acids derived  
+
we planned the creation of a fusion protein that has the capability to activate amino acids derived  
 
from NRPSs´ A-domain PheA and tRNA binding capabilities derived from a part of multi aaRSs  
 
from NRPSs´ A-domain PheA and tRNA binding capabilities derived from a part of multi aaRSs  
 
complexes Arc1p-C.
 
complexes Arc1p-C.
Line 16: Line 16:
 
The PheA domain was amplified from the PheA-Arc1p-C-2x-pET28a construct and inserted into the  
 
The PheA domain was amplified from the PheA-Arc1p-C-2x-pET28a construct and inserted into the  
 
linearized pET28a (XhoI, NdeI) cloning vector by Gibson assembly.  To amplify the resulting  
 
linearized pET28a (XhoI, NdeI) cloning vector by Gibson assembly.  To amplify the resulting  
plasmid ''Escherichia coli'' Top10 cells were transformed.
+
plasmid ''Escherichia coli'' Top10 cells were transformed with it.
  
  
Line 22: Line 22:
  
 
After cloning procedures were successfully completed, a test expression of PheA was performed.  
 
After cloning procedures were successfully completed, a test expression of PheA was performed.  
Therefore ''E. coli'' BL21 (DE3) was transformed with the PheA plasmid. For the expression test,  
+
Therefore ''E. coli'' BL21 (DE3) was transformed with the PheA containing plasmid. For the expression test,  
 
a 60 mL culture was grown to an OD of 0.5 and induced with 100 µM IPTG. Pre-induction (PI),  
 
a 60 mL culture was grown to an OD of 0.5 and induced with 100 µM IPTG. Pre-induction (PI),  
 
induction (I) and two elution (E1, E2) fractions from the Ni-NTA were taken and prepared for  
 
induction (I) and two elution (E1, E2) fractions from the Ni-NTA were taken and prepared for  
Line 29: Line 29:
 
<html><img src="https://static.igem.org/mediawiki/2014/f/f6/BBa_K1329005_1.png" width="50%;" /></html>
 
<html><img src="https://static.igem.org/mediawiki/2014/f/f6/BBa_K1329005_1.png" width="50%;" /></html>
  
Gel analysis reveals that the transformed ''E. coli'' BL21 (DE3) strain produces the PheA on a  
+
Gel analysis reveals that the transformed ''E. coli'' BL21 (DE3) strain produces PheA on a  
small scale. The protein band appears at the expected size of 65 kDa so nevertheless an  
+
small scale. Since the protein band appears at the expected size of 65 kDa an  
overexpression was conducted.
+
overexpression was conducted anyway.
  
 
<html><h2>Production of PheA</h2></html>
 
<html><h2>Production of PheA</h2></html>
  
 
Since the expression test was successful, protein expression was scaled up. For that purpose,  
 
Since the expression test was successful, protein expression was scaled up. For that purpose,  
an expression culture was inoculated and induced with 100 µM IPTG by an OD of 0.5.
+
an expression culture was inoculated and induced with 100 µM IPTG until an OD of 0.5.
  
  
Line 43: Line 43:
 
Cells were harvested and the pellet was resuspended in buffer A before lysing the cells using  
 
Cells were harvested and the pellet was resuspended in buffer A before lysing the cells using  
 
a french press. After centrifugation the cleared supernatant (Load) was loaded on a column  
 
a french press. After centrifugation the cleared supernatant (Load) was loaded on a column  
with Ni-NTA agarose by Qiagen. Gel analysis revealed that a band of the expected size is present  
+
with Ni-NTA agarose by Qiagen. Gel analysis reveal that a band of the expected size is present  
 
in the elution fraction of the Ni-NTA. The eluted protein was concentrated and further purified  
 
in the elution fraction of the Ni-NTA. The eluted protein was concentrated and further purified  
 
using an anion exchanger. Possible fractions were analysed by SDS-PAGE.
 
using an anion exchanger. Possible fractions were analysed by SDS-PAGE.
Line 49: Line 49:
 
<html><img src="https://static.igem.org/mediawiki/2014/d/da/BBa_K1329005_2.jpg" width="70%;" /></html>
 
<html><img src="https://static.igem.org/mediawiki/2014/d/da/BBa_K1329005_2.jpg" width="70%;" /></html>
  
Gel analysis revealed that a band of the expected size is present in the fraction 4 and 5.  
+
Gel analysis reveal that a band of the expected size is present in fraction 4 and 5.  
The eluted protein was concentrated and further purified by dialysis. The fractions were  
+
The eluted protein was concentrated and further purified by dialysis. Fractions containing PheA were  
 
concentrated and stored at -80 °C until further use.
 
concentrated and stored at -80 °C until further use.
  
Line 59: Line 59:
 
of ATP. The reaction was stopped by the addition of sodium acetate, tRNA was precipitated with  
 
of ATP. The reaction was stopped by the addition of sodium acetate, tRNA was precipitated with  
 
ethanol and purified by size exclusion chromatography. Half of the sample was treated with base,  
 
ethanol and purified by size exclusion chromatography. Half of the sample was treated with base,  
reacidified and analysed by LCMS.
+
reacidified and analyzed by LCMS.
  
 
<html><img src="https://static.igem.org/mediawiki/2014/a/a9/BBa_K1329004_2.png" width="100%;" /></html>
 
<html><img src="https://static.igem.org/mediawiki/2014/a/a9/BBa_K1329004_2.png" width="100%;" /></html>

Latest revision as of 17:09, 17 October 2014

NRPS: Amino acid activation domain

Idea

Our approach was to realization the advantages of the nonribosomal peptide synthesis (NRPS) with the ribosomal pathway, i.e. the enormous repertoire of amino acids combined with the ability of the ribosome to synthesize huge proteins. To reach that aim, we planned the creation of a fusion protein that has the capability to activate amino acids derived from NRPSs´ A-domain PheA and tRNA binding capabilities derived from a part of multi aaRSs complexes Arc1p-C.


Cloning procedure

The PheA domain was amplified from the PheA-Arc1p-C-2x-pET28a construct and inserted into the linearized pET28a (XhoI, NdeI) cloning vector by Gibson assembly. To amplify the resulting plasmid Escherichia coli Top10 cells were transformed with it.


Test expression of PheA

After cloning procedures were successfully completed, a test expression of PheA was performed. Therefore E. coli BL21 (DE3) was transformed with the PheA containing plasmid. For the expression test, a 60 mL culture was grown to an OD of 0.5 and induced with 100 µM IPTG. Pre-induction (PI), induction (I) and two elution (E1, E2) fractions from the Ni-NTA were taken and prepared for SDS-PAGE analysis.

Gel analysis reveals that the transformed E. coli BL21 (DE3) strain produces PheA on a small scale. Since the protein band appears at the expected size of 65 kDa an overexpression was conducted anyway.

Production of PheA

Since the expression test was successful, protein expression was scaled up. For that purpose, an expression culture was inoculated and induced with 100 µM IPTG until an OD of 0.5.


Ni-NTA with anion exchanger and dialysis of PheA

Cells were harvested and the pellet was resuspended in buffer A before lysing the cells using a french press. After centrifugation the cleared supernatant (Load) was loaded on a column with Ni-NTA agarose by Qiagen. Gel analysis reveal that a band of the expected size is present in the elution fraction of the Ni-NTA. The eluted protein was concentrated and further purified using an anion exchanger. Possible fractions were analysed by SDS-PAGE.

Gel analysis reveal that a band of the expected size is present in fraction 4 and 5. The eluted protein was concentrated and further purified by dialysis. Fractions containing PheA were concentrated and stored at -80 °C until further use.


Measurement of aminoacylation levels

tRNA, amino acid and the fusion protein were incubated and the reaction started by the addition of ATP. The reaction was stopped by the addition of sodium acetate, tRNA was precipitated with ethanol and purified by size exclusion chromatography. Half of the sample was treated with base, reacidified and analyzed by LCMS.

Measurements showed that all fusion constructs were able to load L- as well as D-phenylalanine onto tRNAPhe (Figure 2 a). The varying linker length showed a clear influence on the yield levels with the 2x-GSSG linker showing the highest catalytic activity yielding 11% loaded tRNA after 30 min while the 8x-construct reached only a maximum of 3% loaded tRNA as well as the linker-less version. The remaining constructs showed intermediate results. Furthermore the linking of the two domains leading to the increase in reactant concentration and the correct spatial arrangement is indeed important for the catalytic effect to occur since a mixture of the unlinked domains showed only background levels of aminoacylation (Figure 2 b). Further negative controls included testing the reaction without enzyme or ATP. As a positive control to evaluate the method phenylalanyl-tRNA synthetase (PheRS) was used. A time-dependent measurement of the aminoacylation level showed that a maximum is reached after 30 min (Figure 2 c). To test if other tRNAs except for the tRNAPhe can be aminoacylated using our fusion construct we carried out aminoacylation assays with five additional E. coli tRNAs (Figure 2 d). The measurements suggest in agreement with previous studies that all tRNAs were loaded similarly well.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 577
    Illegal AgeI site found at 736
    Illegal AgeI site found at 1228
  • 1000
    COMPATIBLE WITH RFC[1000]